Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Cancer Res ; 80(18): 3906-3919, 2020 09 15.
Article in English | MEDLINE | ID: mdl-32699136

ABSTRACT

Extracellular ATP (eATP) is a signaling molecule that variably affects all cells of the immune system either directly or after hydrolysis to adenosine. Although eATP is virtually absent in the interstitium of normal tissues, it can be present in the hundreds of micromolar range in tumors, a concentration compatible with activation of the ATP-gated ionotropic P2X7 receptor. Here, we show that P2X7 activity in tumor-infiltrating lymphocytes (TIL) induces cellular senescence and limits tumor suppression. P2X7 stimulation affected cell cycling of effector T cells and resulted in generation of mitochondrial reactive oxygen species and p38 MAPK-dependent upregulation of cyclin-dependent kinase inhibitor 1A (Cdkn1a, encoding for p21Waf1/Cip1). Lack of P2X7 promoted a transcriptional signature that correlated with enhanced cytotoxic T-cell response in human solid tumors. In mice, transfer of tumor-specific T cells with deletion of P2rx7 significantly reduced tumor growth and extended survival. Collectively, these findings uncover a purinergic checkpoint that can be targeted to improve the efficacy of cancer immunotherapy strategies. SIGNIFICANCE: These findings suggest that the purinergic checkpoint P2X7 may be targeted to enhance T-cell-mediated cancer immunotherapy and improve T effector cell accumulation in the tumor microenvironment. GRAPHICAL ABSTRACT: http://cancerres.aacrjournals.org/content/canres/80/18/3906/F1.large.jpg.


Subject(s)
Cell Migration Inhibition , Cellular Senescence/immunology , Lymphocytes, Tumor-Infiltrating/immunology , Lymphocytes, Tumor-Infiltrating/metabolism , Melanoma, Experimental/immunology , Receptors, Purinergic P2X7/metabolism , Adenosine Triphosphate/metabolism , Animals , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Cell Cycle , Cell Line, Tumor , Cyclin-Dependent Kinase Inhibitor p21/metabolism , Flow Cytometry/methods , Gene Expression Profiling , Humans , Immune Checkpoint Inhibitors/therapeutic use , Immunotherapy, Adoptive/methods , Melanoma, Experimental/pathology , Melanoma, Experimental/therapy , Mice , Mice, Inbred C57BL , Mitochondria/metabolism , Neoplasm Transplantation , Purinergic P2X Receptor Antagonists , Reactive Oxygen Species/metabolism , Receptors, Purinergic P2X7/deficiency , T-Lymphocytes, Cytotoxic/immunology , Transcription, Genetic , Tumor Microenvironment/immunology , Up-Regulation
2.
J Exp Med ; 216(2): 317-336, 2019 02 04.
Article in English | MEDLINE | ID: mdl-30655308

ABSTRACT

Altered control of T follicular helper (Tfh) cells can lead to generation of autoantibodies and autoimmune manifestations. Signaling pathways that selectively limit pathogenic responses without affecting the protective function of Tfh cells are unknown. Here we show that the ATP-gated ionotropic P2X7 receptor restricts the expansion of aberrant Tfh cells and the generation of self-reactive antibodies in experimental murine lupus, but its activity is dispensable for the expansion of antigen-specific Tfh cells during vaccination. P2X7 stimulation promotes caspase-mediated pyroptosis of Tfh cells and controls the development of pathogenic ICOS+ IFN-γ-secreting cells. Circulating Tfh cells from patients with systemic lupus erythematosus (SLE) but not primary antiphospholipid syndrome (PAPS), a nonlupus systemic autoimmune disease, were hyporesponsive to P2X7 stimulation and resistant to P2X7-mediated inhibition of cytokine-driven expansion. These data point to the P2X7 receptor as a checkpoint regulator of Tfh cells; thus, restoring P2X7 activity in SLE patients could selectively limit the progressive amplification of pathogenic autoantibodies, which deteriorate patients' conditions.


Subject(s)
Lupus Erythematosus, Systemic/immunology , Receptors, Purinergic P2X7/immunology , T-Lymphocytes, Helper-Inducer/immunology , Animals , Autoantibodies/genetics , Autoantibodies/immunology , Disease Models, Animal , Interferon-gamma/genetics , Interferon-gamma/immunology , Lupus Erythematosus, Systemic/genetics , Lupus Erythematosus, Systemic/pathology , Mice , Mice, Knockout , Pyroptosis/genetics , Pyroptosis/immunology , Receptors, Purinergic P2X7/genetics , T-Lymphocytes, Helper-Inducer/pathology
3.
Nat Commun ; 8(1): 1917, 2017 12 04.
Article in English | MEDLINE | ID: mdl-29203869

ABSTRACT

The melastatin-like transient-receptor-potential-7 protein (TRPM7), harbouring a cation channel and a serine/threonine kinase, has been implicated in thymopoiesis and cytokine expression. Here we show, by analysing TRPM7 kinase-dead mutant (Trpm7 R/R ) mice, that the enzymatic activity of the receptor is not essential for thymopoiesis, but is required for CD103 transcription and gut-homing of intra-epithelial lymphocytes. Defective T cell gut colonization reduces MHCII expression in intestinal epithelial cells. Mechanistically, TRPM7 kinase activity controls TGF-ß-induced CD103 expression and pro-inflammatory T helper 17, but not regulatory T, cell differentiation by modulating SMAD2. Notably, we find that the TRPM7 kinase activity promotes gut colonization by alloreactive T cells in acute graft-versus-host disease. Thus, our results unravel a function of TRPM7 kinase in T cell activity and suggest a therapeutic potential of kinase inhibitors in averting acute graft-versus-host disease.


Subject(s)
Graft vs Host Disease/genetics , Intestines/immunology , Lymphopoiesis/genetics , T-Lymphocytes, Regulatory/cytology , TRPM Cation Channels/genetics , Th17 Cells/cytology , Animals , Antigens, CD/immunology , Cell Differentiation/genetics , Genes, MHC Class II/genetics , Genes, MHC Class II/immunology , Graft vs Host Disease/immunology , Integrin alpha Chains/immunology , Mice , Mutation , Smad2 Protein/immunology , T-Lymphocytes/cytology , T-Lymphocytes/immunology , T-Lymphocytes, Regulatory/immunology , TRPM Cation Channels/immunology , Th17 Cells/immunology , Transforming Growth Factor beta/immunology
4.
Sci Rep ; 6: 24515, 2016 Apr 15.
Article in English | MEDLINE | ID: mdl-27079797

ABSTRACT

The pathogenic role of SOD1 mutations in amyotrophic lateral sclerosis (ALS) was investigated using a zebrafish disease model stably expressing the ALS-linked G93R mutation. In addition to the main pathological features of ALS shown by adult fish, we found remarkably precocious alterations in the development of motor nerve circuitry and embryo behavior, and suggest that these alterations are prompted by interneuron and motor neuron hyperexcitability triggered by anomalies in the persistent pacemaker sodium current INaP. The riluzole-induced modulation of INaP reduced spinal neuron excitability, reverted the behavioral phenotypes and improved the deficits in motor nerve circuitry development, thus shedding new light on the use of riluzole in the management of ALS. Our findings provide a valid phenotype-based tool for unbiased in vivo drug screening that can be used to develop new therapies.


Subject(s)
Action Potentials/drug effects , Action Potentials/genetics , Amyotrophic Lateral Sclerosis/genetics , Motor Neurons/drug effects , Motor Neurons/physiology , Phenylglyoxal/analogs & derivatives , Superoxide Dismutase/genetics , Amyotrophic Lateral Sclerosis/diagnosis , Animals , Animals, Genetically Modified , Disease Models, Animal , Gene Expression , Locomotion , Motor Activity/drug effects , Muscles/pathology , Mutation , Neuromuscular Junction/metabolism , Phenotype , Phenylglyoxal/pharmacology , Riluzole/pharmacology , Spinal Cord/pathology , Zebrafish
SELECTION OF CITATIONS
SEARCH DETAIL
...